-
1 Comment
Selvita S.A. is currently in a long term uptrend where the price is trading 36.0% above its 200 day moving average.
Its net income has increased by 1829.8% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 793.0% to $2M since the same quarter in the previous year.
Based on the above factors, Selvita S.A. gets an overall score of 3/5.
| ISIN | PLSLVCR00029 |
|---|---|
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CurrencyCode | PLN |
| Exchange | WAR |
| PE Ratio | 7440.0 |
|---|---|
| Market Cap | 1B |
| Beta | 0.04 |
| Dividend Yield | 0.0% |
| Target Price | 90.03 |
Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Kraków, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SLV.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
